logo

For the Inventor, By the Inventor

Hoover, AL, United States of America

Xini Zhang

This inventor holds 6 USPTO granted patents. Top assignees: The Picower Institute for Medical Research, Gem Pharmaceuticals, LLC, Other. Active years: 1997-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xini Zhang. Retrieved from https://idiyas.com/inventor/xini-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 115(Granted Patents)


Location History:

  • Wilmington, DE (US) (1997)
  • Hoover, AL (US) (1998 - 1999)
  • Jericho, NJ (US) (1999)
  • Jericho, NY (US) (2002)

Company Filing History:

goldMedal3 out of 67 
 
The Picower Institute for Medical Research
 patents
silverMedal2 out of 7 
 
Gem Pharmaceuticals, LLC
 patents
bronzeMedal1 out of 834,601 
Other
 patents

Years Active: 1997-2002

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6410598 - Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis (2002-06-25),
2. 5948896 - Processes for preparing 13-deoxy anthracycline derivatives (1999-09-07),
3. 5942605 - 5-imino-13-deoxy anthracycline derivatives, their uses, and processes (1999-08-24),
4. 5935927 - Compositions and methods for stimulating amyloid removal in (1999-08-10),
5. 5814664 - 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced (1998-09-29),
6. 5688653 - 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced (1997-11-18),

Title: Innovations and Contributions of Inventor Xini Zhang

Introduction

Xini Zhang is a notable inventor based in Hoover, Alabama, with a significant portfolio of six patents. His work primarily focuses on advancements in medical research, particularly in the fields of amyloidosis and anthracycline derivatives. Zhang's contributions have the potential to impact the treatment of neurodegenerative diseases and diabetes.

Latest Patents

One of Zhang's latest patents is titled "Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis." This invention addresses the non-enzymatic glycosylation of amyloidogenic proteins, which can enhance amyloidosis. The patent outlines methods for preventing and treating amyloidosis associated with diseases such as Alzheimer's and Type II diabetes. Another significant patent involves "Processes for preparing 13-deoxy anthracycline derivatives," which details a method for synthesizing these important compounds.

Career Highlights

Throughout his career, Xini Zhang has worked with esteemed organizations, including the Picower Institute for Medical Research and Gem Pharmaceuticals, LLC. His experience in these institutions has allowed him to develop innovative solutions to complex medical challenges.

Collaborations

Zhang has collaborated with notable professionals in his field, including Peter C. Ulrich and Anthony Cerami. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Xini Zhang's innovative work in the field of medical research showcases his dedication to addressing critical health issues. His patents reflect a commitment to improving treatment options for diseases that significantly impact quality of life.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…